POSC35 Venetoclax Combination Therapies Show Significant Improvements in Overall Survival and Remission in Treatment-Naïve Patients with AML Who Are Ineligible for Intensive Chemotherapy: A Network Meta-Analysis
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.181
https://www.valueinhealthjournal.com/article/S1098-3015(21)01976-8/fulltext
Title :
POSC35 Venetoclax Combination Therapies Show Significant Improvements in Overall Survival and Remission in Treatment-Naïve Patients with AML Who Are Ineligible for Intensive Chemotherapy: A Network Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01976-8&doi=10.1016/j.jval.2021.11.181
First page :
Section Title :
Open access? :
No
Section Order :
10948